ID   K-TL-1
AC   CVCL_A7PB
SY   KTL-1
DR   Wikidata; Q107115519
RX   PubMed=2365902;
RX   PubMed=2789154;
RX   PubMed=6165463;
CC   Population: Japanese.
CC   Doubling time: 10 days (PubMed=6165463).
CC   Derived from site: In situ; Hair follicle, outer root sheath; UBERON=UBERON_0005942.
DI   NCIt; C4113; Trichilemmoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   68Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 14-08-25; Version: 6
//
RX   PubMed=2365902; DOI=10.1111/j.1346-8138.1990.tb01627.x;
RA   Nishioka, Kiyoshi
RA   Funato, Tadao
RA   Sato, Yuko
RA   Ohta, Yukinori
RA   Eto, Hikaru
RA   Katayama, Ichiro
RA   Nishiyama, Shigeo
RT   "Production of interleukin 1 alpha by a trichilemmoma cell line.";
RL   J. Dermatol. 17:205-210(1990).
//
RX   PubMed=6165463;
RA   Kanzaki, Tamotsu
RA   Eto, Hikaru
RA   Umezawa, Akira
RA   Maeda, Tohru
RA   Iwase, Hitoo
RA   Ito, Masatsugu
RT   "Morphological, biological, and biochemical characteristics of a
RT   benign human trichilemmoma cell line in vivo and in vitro.";
RL   Cancer Res. 41:2468-2475(1981).
//
RX   PubMed=2789154; DOI=10.1159/000248477;
RA   Nishioka, Kiyoshi
RA   Katayama, Ichiro
RA   Eto, Hikaru
RA   Funato, Tadao
RT   "A trichilemmoma cell line can generate interleukin-1-alpha.";
RL   Dermatologica 179 Suppl. 1:135-136(1989).
//